Feb 10, 2015 3:28:00 PM
With the SLAS tagline ‘Come Transform Research’, we feel very much at home at this year’s Annual Conference and Exhibition, especially since we have come to launch a brand new system – Gyrolab xPlore, a smaller companion to Gyrolab xP workstation!
Topics: Assay Automation, Biomarkers, Pharmacokinetics, Serial sampling, Microsampling
Dec 22, 2014 9:19:00 AM
.png)
George Hu and his colleagues (1) at Pfizer have improved the predictive power of their pharmacokinetic (PK) models by replacing an anti-drug conjugate (ADC) target in mice with the human version, yielding more relevant data from their preclinical study. Their work focused on trophoblast glycoprotein (TPBG), a target of several therapeutic anti-tumor cancer agents currently in the development pipeline. Mice were engineered to express human TPBG. Hu’s group then studied the pharmacokinetics of a clinical-stage anti-TPBG ADC (A1mcMMAF) in wild-type mice and ‘knock-in’ hTPBG mice.
Topics: Pharmacokinetics, Serial sampling, Microsampling
Oct 8, 2014 10:09:00 PM
The importance of minimizing animal use was highlighted in the
Topics: Pharmacokinetics, Serial sampling, Microsampling
Sep 1, 2014 4:44:00 PM
The importance of minimizing animal use was highlighted in the Nordic Prize for Alternatives to Animal Experiments 2014, awarded at the Digital Health Days conference, held in late August in Stockholm, to Christel Bergström, Maria Karlgren and Pär Matsson at Uppsala University for their contribution of animal-free methods in drug development. The team has used cell models and computer models to study intestinal drug transport, side effects and drug interactions. Using these screening and predictive methods prior to preclinical testing will aid drug design and identify benefits and risks early on, thus reducing animal testing.
Topics: Pharmacokinetics, Serial sampling, Microsampling
Get in touch
